Tropheryma whipplei nucleic acid IVD, kit, nucleic acid technique (NAT)
- Device ID
- 130282
- MHRA Reference Number
- 130282
- Date Registered
- Nov 26, 2024
- Last Updated
- Oct 8, 2024
- Device Type
- In Vitro Diagnostic Device
- Devices
- Tropheryma whipplei nucleic acid IVD, kit, nucleic acid technique (NAT)
- Type
- IVD General
- Address
- Calle Valle de la Ballestera, 56 46015 Valencia, 46015 Valencia , Spain
- Created Date
- Dec 1, 2021
- Name
- Werfen Ltd
- Relationship Type
- UK Responsible Person
- Address
- 712 The Quadrant, Cavendish Avenue, Birchwood, Warrington WA3 6DE ManchesterManchester, England, United KingdomPostcode: WA3 6DE
Devices with a matching generic name or device type registered with MHRA
Additional devices registered by the same manufacturer
Additional devices represented by Werfen Ltd in the UK
Tropheryma whipplei nucleic acid IVD, kit, nucleic acid technique (NAT) is a medical device registered with the UK's Medicines and Healthcare products Regulatory Agency (MHRA) under Device ID 130282. The device is manufactured by Progenie Molecular SLU from Spain, classified as In Vitro Diagnostic Device. The authorized representative in the UK is Werfen Ltd.
This page provides comprehensive regulatory information including complete registration details, manufacturer information, device classification, authorized representative details, and related products. Pure Global AI offers free access to 150,962+ UK MHRA medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.